Newly synthesized biscoumarins are endowed with a promising profile of biological activities that include inhibition of cholinesterases, reduction in the proliferation of cancer cells without any toxic effect against normal fibroblasts, crossing the BBB, and dual-binding site character in the gorge of hAChE. The gene discussed is BCHE; the disease is cancer.